# Boxer Capital: portfolio, investments and team > Boxer Capital is a vc firm based in United States. 17 investments on record, latest Oct 2025. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/boxer-capital (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Boxer Capital Last cheque observed Oct 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet VC firm Seed Series A Series B Biotechnology Precision Medicine Cheques on record **0%** of best year **0** **cheques in 12 months**, 17 on record Since the last cheque **391** days **00** hrs **00** min **00** sec Median round **$80M** Cheque size, as they say **$100K – $5.0M** Rounds led **1 of 17** Sole investor **1 rounds** Mostly in **United States, 88%** Pitch Boxer Capital ## Boxer Capital highlights - 01 17 rounds on record - 02 Mostly Series C and Series B: 69% of its rounds - 03 Sole investor in 1 rounds, median $40M ## What they do > Boxer Capital Management is a full life cycle investment firm, committed to fundamental, research-based investing in specialized and precision medicine companies across private and public markets. From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** $100K – $5.0M as they say - **Stages:** Seed Series A Series B Growth - **Sectors:** Biotechnology Precision Medicine - **Based in:** Windermere, United States - **Cold pitches:** Not accepted ## The record Every round we can evidence, newest first **17 appearances** - **2025** 1 round - **Oct** **[Zag Bio](https://millionrounds.com/company/zag-bio)** Series A · US · Firms' own news pages **$80M** With 9 others - **2019** 8 rounds - **Dec** **[Black Diamon Therapeutics](https://millionrounds.com/company/black-diamon-therapeutics)** Series C · US · FinSMEs **$85M** *Led* - **Nov** **[PMV Pharma](https://millionrounds.com/company/pmv-pharma)** Series C · US · Prweb **$62M** With 7 others - **Jul** **[Revolution Medicines](https://millionrounds.com/company/revolution-medicines)** Series C · US · FinSMEs **$100M** With 9 others - **Apr** **[Poseida Therapeutics](https://millionrounds.com/company/poseida-therapeutics)** Series C · US · FinSMEs **$142M** With 7 others - **Apr** **[SpringWorks Therapeutics](https://millionrounds.com/company/springworks-therapeutics)** Series B · US · FinSMEs **$125M** With 12 others - **Mar** **[Prevail Therapeutics](https://millionrounds.com/company/prevail-therapeutics)** Series B · US · Medcitynews **$50M** With 10 others - **Jan** **[Attune Pharmaceuticals](https://millionrounds.com/company/attune-pharmaceuticals)** Series B · US · Globenewswire **$23M** With 5 others - **Jan** **[Sojournix](https://millionrounds.com/company/sojournix)** Series C · US · FinSMEs **$44M** With 5 others - **2018** 5 rounds - **Dec** **[Akero Therapeutics](https://millionrounds.com/company/akero-therapeutics)** Series B · US · FinSMEs **$70M** With 9 others - **Oct** **[Milestone Pharmaceuticals](https://millionrounds.com/company/milestone-pharmaceuticals)** CA · FinSMEs **$80M** With 9 others - **Sept** **[Atreca](https://millionrounds.com/company/atreca)** Series C · US · FinSMEs **$125M** With 7 others - **Mar** **[Ideaya](https://millionrounds.com/company/ideaya)** Series B · US · FinSMEs **$94M** With 12 others - **Mar** **[Prevail](https://millionrounds.com/company/prevail)** Series A · FinSMEs **$75M** With 8 others - **2017** 1 round - **Jan** **[CiVi Biopharma](https://millionrounds.com/company/civi-biopharma)** Series A · US · FinSMEs **$40M** Sole investor - **2015** 2 rounds - **Sept** **[AveXis](https://millionrounds.com/company/avexis)** Series D · US **$65M** With 11 others - **Aug** **[Telesta Therapeutics](https://millionrounds.com/company/telesta-therapeutics)** Venture · CA **$29M** With 2 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **5 named** AI **Aaron Isaac Davis** Chief Executive Officer i Form ADV AR **Andrew Ruel Ellis** Chief Legal Officer i Form ADV CF **Christopher Fuglesang** Senior Managing Director i Form ADV MB **Michael Beauchamp** Vp of Finance i Form ADV NT **Natalie Theresa Roberts** Chief Compliance Officer i Form ADV We also hold **12** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$578M** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Boxer Capital Management, LLC - **SEC number:** CRD 330106 Funds on its Form ADV **1** private fund, **$2.5B** in gross assets · filed Nov 2024 - Boxer Capital, LLC *Hedge* 6 investors $2.5B ## The cheque Seed Series A Series B Median round joined **$80M** the round, not its cheque Alone, median **$40M** Led 1 of 17 rounds **6%** - **Said size:** $100K – $5.0M - **Sole investor:** 1 rounds - **Last cheque:** Oct 2025 Rounds by stage said on their site - Series C *6* - Series B said *5* - Series A said *3* - Series D *1* - Venture *1* - Seed said *-* - Growth said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [BVF Partners](https://millionrounds.com/fund/bvf-partners) 6 - [OrbiMed](https://millionrounds.com/fund/orbimed) 4 - [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 4 - [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 3 - [Cormorant Capital](https://millionrounds.com/fund/cormorant-capital) 3 - [Deerfield](https://millionrounds.com/fund/deerfield) 3 **Pitching Boxer Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Boxer Capital. A count of rooms they were both in, not a relationship either has claimed. [**BVF Partners** VC firm **6** rounds together](https://millionrounds.com/fund/bvf-partners)[**OrbiMed** Private equity **4** rounds together](https://millionrounds.com/fund/orbimed)[**RA Capital Management** Private equity **4** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Alexandria Real Estate Equities** VC firm **3** rounds together](https://millionrounds.com/fund/alexandria)[**Cormorant Capital** VC firm **3** rounds together](https://millionrounds.com/fund/cormorant-capital)[**Deerfield** VC firm **3** rounds together](https://millionrounds.com/fund/deerfield)[**EcoR1 Capital** Private equity **3** rounds together](https://millionrounds.com/fund/ecor1-capital)[**Omega Funds** VC firm **3** rounds together](https://millionrounds.com/fund/omega-funds)[**Venrock** VC firm **3** rounds together](https://millionrounds.com/fund/venrock)[**AbbVie** Corporate VC **2** rounds together](https://millionrounds.com/fund/abbvie)[**Adage Capital Management** Asset manager **2** rounds together](https://millionrounds.com/fund/adage-capital-management)[**Casdin Capital** VC firm **2** rounds together](https://millionrounds.com/fund/casdin-capital) ## Recently backed The latest companies Boxer Capital put money into. [**Zag Bio** $80M · Oct 2025](https://millionrounds.com/company/zag-bio)[**Revolution Medicines** $100M · Jul 2019](https://millionrounds.com/company/revolution-medicines)[**SpringWorks Therapeutics** $125M · Apr 2019](https://millionrounds.com/company/springworks-therapeutics)[**Akero Therapeutics** $70M · Dec 2018](https://millionrounds.com/company/akero-therapeutics)[**Milestone Pharmaceuticals** $80M · Oct 2018](https://millionrounds.com/company/milestone-pharmaceuticals)[**CiVi Biopharma** $40M · Jan 2017](https://millionrounds.com/company/civi-biopharma) ## Quick answers about Boxer Capital ### What does Boxer Capital invest in? Boxer Capital invests most often at Series C and Series B (69% of the rounds on record), in sectors such as Biotechnology and Precision Medicine. ### How active is Boxer Capital? 17 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Oct 2025. ### What has Boxer Capital invested in recently? Its most recent investments on record: Zag Bio (Series A, Oct 2025), Black Diamon Therapeutics (Series C, Dec 2019) and PMV Pharma (Series C, Nov 2019). ### How big are Boxer Capital's cheques? The median round it joins is $80M. It says it writes cheques of $100K to $5.0M. ### Does Boxer Capital lead rounds? Sometimes: it led 1 of its 17 investments on record (6%). ### Where does Boxer Capital invest? Most of the companies it backs are in the United States (88%) and Canada (13%). ### Is Boxer Capital investing now? No investments in the last 12 months; the latest was in Oct 2025. ### Who does Boxer Capital invest alongside? Most often BVF Partners (6 rounds together), OrbiMed (4 rounds together) and RA Capital Management (4 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=boxer-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=boxer-capital)